Kevan Clemens - Net Worth and Insider Trading

Kevan Clemens Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevan Clemens owns 1 companies in total, including MEI Pharma Inc (MEIP) .

Click here to see the complete history of Kevan Clemens’s form 4 insider trades.

Insider Ownership Summary of Kevan Clemens

Ticker Comapny Transaction Date Type of Owner
MEIP MEI Pharma Inc 2020-07-02 director

Kevan Clemens Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Kevan Clemens Ownership Network

Ownership Network List of Kevan Clemens

No Data

Ownership Network Relation of Kevan Clemens

Insider Network Chart

Kevan Clemens Owned Company Details

What does MEI Pharma Inc do?

Who are the key executives at MEI Pharma Inc?

Kevan Clemens is the director of MEI Pharma Inc. Other key executives at MEI Pharma Inc include Chief Medical Officer Richard G Ghalie , 10 percent owner Amin Nathoo , and 10 percent owner Funicular Funds, Lp .

MEI Pharma Inc (MEIP) Insider Trades Summary

Over the past 18 months, Kevan Clemens made no insider transaction in MEI Pharma Inc (MEIP). Other recent insider transactions involving MEI Pharma Inc (MEIP) include a net purchase of 201,660 shares made by Anson Funds Management Lp , and a net purchase of 134,440 shares made by Funicular Funds, Lp .

In summary, during the past 3 months, insiders sold 0 shares of MEI Pharma Inc (MEIP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MEI Pharma Inc (MEIP) were sold and 336,100 shares were bought by its insiders, resulting in a net purchase of 336,100 shares.

MEI Pharma Inc (MEIP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

MEI Pharma Inc Insider Transactions

No Available Data

Kevan Clemens Mailing Address

Above is the net worth, insider trading, and ownership report for Kevan Clemens. You might contact Kevan Clemens via mailing address: C/o Chelsea Therapeutics, Inc., 13950 Ballantyne Corporate Pl Suite 325, Charlotte Nc 28277.